Annette North Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Annette North.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Annette North. Annette North is General Counsel in SGX PHARMACEUTICALS, INC. ($SGXP) and VP, Corp Affairs & Legal in SGX PHARMACEUTICALS, INC. ($SGXP) and VP, Legal Affairs & Secretary in SGX PHARMACEUTICALS, INC. ($SGXP) and SVP, General Counsel in Kura Oncology, Inc. ($KURA) and EVP, General Counsel & Secty. in Turning Point Therapeutics, Inc. ($TPTX).
Latest Insider Trading Transactions of Annette North
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, KURA, SGXP, TPTX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 07 2021 | TPTX | Turning Point Ther ... | North Annette | EVP, General Counse ... | Option Exercise | M | 17.00 | 5,882 | 99,994 | 169,609 | |
| May 07 2021 | TPTX | Turning Point Ther ... | North Annette | EVP, General Counse ... | Buy | M | 17.00 | 5,882 | 99,994 | 12,365 | 6.5 K to 12.4 K (+90.73 %) |
| Mar 09 2021 | TPTX | Turning Point Ther ... | North Annette | EVP, General Counse ... | Option Exercise | M | 17.00 | 20,000 | 340,000 | 175,491 | |
| Mar 09 2021 | TPTX | Turning Point Ther ... | North Annette | EVP, General Counse ... | Sell | S | 111.69 | 700 | 78,183 | 6,483 | 7.2 K to 6.5 K (-9.75 %) |
| Mar 09 2021 | TPTX | Turning Point Ther ... | North Annette | EVP, General Counse ... | Sell | S | 110.77 | 4,571 | 506,330 | 7,183 | 11.8 K to 7.2 K (-38.89 %) |
| Mar 09 2021 | TPTX | Turning Point Ther ... | North Annette | EVP, General Counse ... | Sell | S | 109.89 | 9,419 | 1,035,054 | 11,754 | 21.2 K to 11.8 K (-44.49 %) |
| Mar 09 2021 | TPTX | Turning Point Ther ... | North Annette | EVP, General Counse ... | Sell | S | 109.09 | 4,810 | 524,723 | 21,173 | 26 K to 21.2 K (-18.51 %) |
| Mar 09 2021 | TPTX | Turning Point Ther ... | North Annette | EVP, General Counse ... | Sell | S | 103.30 | 500 | 51,650 | 25,983 | 26.5 K to 26 K (-1.89 %) |
| Mar 09 2021 | TPTX | Turning Point Ther ... | North Annette | EVP, General Counse ... | Buy | M | 17.00 | 20,000 | 340,000 | 26,483 | 6.5 K to 26.5 K (+308.50 %) |
| Feb 10 2021 | TPTX | Turning Point Ther ... | North Annette | EVP, General Counse ... | Option Exercise | A | 140.01 | 29,175 | 4,084,792 | 29,175 | |
| Feb 10 2021 | TPTX | Turning Point Ther ... | North Annette | EVP, General Counse ... | Grant | A | 0.00 | 6,483 | 0 | 6,483 | 0 to 6.5 K |
| Feb 02 2021 | TPTX | Turning Point Ther ... | North Annette | EVP, General Counse ... | Option Exercise | M | 17.00 | 9,016 | 153,272 | 195,491 | |
| Feb 02 2021 | TPTX | Turning Point Ther ... | North Annette | EVP, General Counse ... | Option Exercise | M | 17.00 | 15,984 | 271,728 | 204,507 | |
| Feb 02 2021 | TPTX | Turning Point Ther ... | North Annette | EVP, General Counse ... | Sell | S | 131.89 | 604 | 79,662 | 0 | 604 to 0 (-100.00 %) |
| Feb 02 2021 | TPTX | Turning Point Ther ... | North Annette | EVP, General Counse ... | Sell | S | 130.64 | 3,752 | 490,161 | 604 | 4.4 K to 604 (-86.13 %) |
| Feb 02 2021 | TPTX | Turning Point Ther ... | North Annette | EVP, General Counse ... | Sell | S | 129.75 | 2,860 | 371,085 | 4,356 | 7.2 K to 4.4 K (-39.63 %) |
| Feb 02 2021 | TPTX | Turning Point Ther ... | North Annette | EVP, General Counse ... | Sell | S | 128.74 | 500 | 64,370 | 7,216 | 7.7 K to 7.2 K (-6.48 %) |
| Feb 02 2021 | TPTX | Turning Point Ther ... | North Annette | EVP, General Counse ... | Sell | S | 127.83 | 900 | 115,047 | 7,716 | 8.6 K to 7.7 K (-10.45 %) |
| Feb 02 2021 | TPTX | Turning Point Ther ... | North Annette | EVP, General Counse ... | Sell | S | 126.66 | 400 | 50,664 | 8,616 | 9 K to 8.6 K (-4.44 %) |
| Feb 02 2021 | TPTX | Turning Point Ther ... | North Annette | EVP, General Counse ... | Buy | M | 17.00 | 9,016 | 153,272 | 9,016 | 0 to 9 K |
| Feb 02 2021 | TPTX | Turning Point Ther ... | North Annette | EVP, General Counse ... | Sell | S | 125.38 | 500 | 62,690 | 0 | 500 to 0 (-100.00 %) |
| Feb 02 2021 | TPTX | Turning Point Ther ... | North Annette | EVP, General Counse ... | Sell | S | 124.41 | 3,313 | 412,170 | 500 | 3.8 K to 500 (-86.89 %) |
| Feb 02 2021 | TPTX | Turning Point Ther ... | North Annette | EVP, General Counse ... | Sell | S | 123.49 | 10,541 | 1,301,708 | 3,813 | 14.4 K to 3.8 K (-73.44 %) |
| Feb 02 2021 | TPTX | Turning Point Ther ... | North Annette | EVP, General Counse ... | Sell | S | 122.58 | 1,630 | 199,805 | 14,354 | 16 K to 14.4 K (-10.20 %) |
| Feb 02 2021 | TPTX | Turning Point Ther ... | North Annette | EVP, General Counse ... | Buy | M | 17.00 | 15,984 | 271,728 | 15,984 | 0 to 16 K |
| Jan 08 2020 | TPTX | Turning Point Ther ... | North Annette | EVP, General Counse ... | Option Exercise | A | 63.33 | 56,000 | 3,546,480 | 56,000 | |
| Jan 24 2019 | KURA | Kura Oncology, Inc ... | North Annette | SVP, General Counse ... | Option Exercise | A | 15.47 | 100,000 | 1,547,000 | 100,000 | |
| Jan 26 2018 | KURA | Kura Oncology, Inc ... | North Annette | SVP, General Counse ... | Option Exercise | A | 20.00 | 70,000 | 1,400,000 | 70,000 | |
| Jan 25 2017 | KURA | Kura Oncology, Inc ... | North Annette | SVP, General Counse ... | Option Exercise | A | 6.15 | 72,000 | 442,800 | 72,000 | |
| Feb 02 2016 | KURA | Kura Oncology, Inc ... | North Annette | SVP, General Counse ... | Option Exercise | A | 4.80 | 80,000 | 384,000 | 80,000 | |
| Apr 27 2015 | KURA | Kura Oncology, Inc ... | North Annette | SVP, General Counse ... | Option Exercise | A | 6.32 | 81,250 | 513,500 | 81,250 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | North Annette | General Counsel | Option Exercise | D | 7.66 | 19,538 | 149,661 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | North Annette | General Counsel | Option Exercise | D | 3.99 | 15,239 | 60,804 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | North Annette | General Counsel | Option Exercise | D | 3.63 | 25,489 | 92,525 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | North Annette | General Counsel | Option Exercise | D | 13.44 | 632 | 8,494 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | North Annette | General Counsel | Option Exercise | D | 13.44 | 948 | 12,741 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | North Annette | General Counsel | Option Exercise | D | 13.44 | 1,896 | 25,482 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | North Annette | General Counsel | Option Exercise | D | 13.44 | 632 | 8,494 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | North Annette | General Counsel | Option Exercise | D | 7.66 | 40,462 | 309,939 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | North Annette | General Counsel | Option Exercise | D | 3.99 | 18,011 | 71,864 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | North Annette | General Counsel | Option Exercise | D | 3.96 | 744 | 2,946 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | North Annette | General Counsel | Option Exercise | D | 3.63 | 24,511 | 88,975 | 0 | |
| Aug 21 2008 | SGXP | SGX PHARMACEUTICAL ... | North Annette | General Counsel | Option Exercise | D | 1.00 | 50,000 | 50,000 | 0 | |
| Feb 25 2008 | SGXP | SGX PHARMACEUTICAL ... | North Annette | General Counsel | Option Exercise | A | 3.99 | 15,239 | 60,804 | 15,239 | |
| Feb 25 2008 | SGXP | SGX PHARMACEUTICAL ... | North Annette | General Counsel | Option Exercise | A | 3.99 | 18,011 | 71,864 | 18,011 | |
| Jan 29 2007 | SGXP | SGX PHARMACEUTICAL ... | North Annette | VP, Corp Affairs & ... | Option Exercise | A | 3.63 | 25,489 | 92,525 | 25,489 | |
| Jan 29 2007 | SGXP | SGX PHARMACEUTICAL ... | North Annette | VP, Corp Affairs & ... | Option Exercise | A | 3.63 | 24,511 | 88,975 | 24,511 | |
| Mar 09 2006 | SGXP | SGX PHARMACEUTICAL ... | North Annette | VP, Legal Affairs & ... | Option Exercise | A | 7.66 | 60,000 | 459,600 | 60,000 |
Page: 1